Drug Approval | June 01, 2026
Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
The approval marks a major milestone in the global fight against antimicrobial resistance
The approval marks a major milestone in the global fight against antimicrobial resistance
The conference highlighted research suggesting that deuterium levels may influence key biological processes
Proprietary technologies in LNP-based delivery of mRNA and DNA vectors to advance T-CURX innovative in vivo CAR-T assets into clinical trials one year earlier
The programme evaluated anselamimab as a first-line add-on to standard plasma cell dyscrasia therapy in patients with advanced cardiac AL amyloidosis
A one-shot gene-editing cholesterol therapy could soon be a reality
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
The approval was granted by Agenzia Italiana del Farmaco
Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth
Subscribe To Our Newsletter & Stay Updated
